A. M. Testi
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
- Multiple Myeloma Research and Treatments
-
- Acute Lymphoblastic Leukemia research
Papers in
-
- Acute Myeloid Leukemia Research 6
- Hematopoietic Stem Cell Transplantation 2
- Chronic Myeloid Leukemia Treatments 2
- Oncology 7
- Neutropenia and Cancer Infections 5
- Lung Cancer Research Studies 2
- Co-authors
- Franco Mandelli (10 shared papers)Sergio Amadori (7 shared papers)Giovanna Meloni (3 shared papers)William Arcese (4 shared papers)M C Petti (2 shared papers)Bruno Monarca (1 shared paper)G Isacchi (1 shared paper)Fiorina Giona (5 shared papers)
In The Last Decade
A. M. Testi
21 papers receiving 345 citations
Peers
Comparison fields: 5 of 42
- Hematology 249
- Public Health, Environmental and Occupational Health 142
- Oncology 118
- Genetics 43
- Clinical Biochemistry 20
Countries citing papers authored by A. M. Testi
This map shows the geographic impact of A. M. Testi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. M. Testi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. M. Testi more than expected).
Fields of papers citing papers by A. M. Testi
This network shows the impact of papers produced by A. M. Testi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. M. Testi. The network helps show where A. M. Testi may publish in the future.
Co-authors
The 25 scholars most cited alongside A. M. Testi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 141 | |
| 2 | 2005 | 54 | |
| 3 | 2005 | 36 | |
| 4 | 1997 | 29 | |
| 5 | 2002 | 19 | |
| 6 | A phase II study of VP-16, intermediate-dose Ara-C and carboplatin (VAC) in advanced acute myelogenous leukemia and blastic chronic myelogenous leukemia. | 1996 | 13 |
| 7 | Evaluation of a polychemotherapeutic regimen including Idarubicin (4-demethoxydaunorubicin) in relapsed acute lymphocytic leukemia. | 1986 | 9 |
| 8 | A single high dose of idarubicin combined with high-dose ABA-C (MSKCC ALL-3 protocol) in adult and pediatric patients with acute lymphoblastic leukemia. Experience at the University La Sapienza of Rome. | 1998 | 8 |
| 9 | 1987 | 8 | |
| 10 | 1992 | 7 | |
| 11 | Central venous catheterization in pediatric patients affected by hematological malignancies. | 1996 | 7 |
| 12 | Immunoglobulin heavy chain and T-cell receptor beta chain gene rearrangements in acute non lymphoid leukemia. | 1990 | 5 |
| 13 | Therapeutic strategies for postremission treatment in childhood acute myeloid leukemia (AML). The AIEOP experience 1987-1991. | 1992 | 4 |
| 14 | 1990 | 3 | |
| 15 | Allogeneic vs autologous BMT vs intensive chemotherapy in childhood AnLL during first complete remission: AIEOP experience. AIEOP Cooperative Group. | 1991 | 2 |
| 16 | The Italian Way of Treating Acute Promyelocytic Leukemia (APL), Final Act | 2003 | 2 |
| 17 | 1987 | 1 | |
| 18 | 1985 | 1 | |
| 19 | Treatment intensification with repeated BFM-protocol II may prevent early relapse in very high risk all AIEOP-ALL 9503 study | 1997 | 1 |
| 20 | Umbilical cord blood (UCB) transplant from unrelated mismatched donor in patients with high risk (HR) leukemia. | 1998 | 1 |
About A. M. Testi
A. M. Testi is a scholar working on Hematology, Oncology, Public Health, Environmental and Occupational Health, Molecular Biology and Genetics, having authored 21 papers that have together received 352 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (7 papers), Acute Myeloid Leukemia Research (6 papers), Neutropenia and Cancer Infections (5 papers), Retinoids in leukemia and cellular processes (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Hematopoietic Stem Cell Transplantation (2 papers), Lung Cancer Research Studies (2 papers) and Chronic Myeloid Leukemia Treatments (2 papers). The work is most often cited by research in Hematology (249 citations), Public Health, Environmental and Occupational Health (142 citations), Oncology (118 citations), Genetics (43 citations) and Clinical Biochemistry (20 citations). A. M. Testi has collaborated with scholars based in Italy, Germany and Argentina. Frequent co-authors include Franco Mandelli, Sergio Amadori, Giovanna Meloni, William Arcese, M C Petti, Bruno Monarca, G Isacchi, Fiorina Giona, Andrea Pession and Piero De Stefano. Their work appears in journals such as Leukemia, Blood, Journal of Clinical Oncology, Clinical Microbiology and Infection and Annals of the Rheumatic Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.